SCHEMBL2967833

SCHEMBL2967833

CCCc1ccc2ccccc2c1[C]1C=Cc2ccccc21

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ GPR84 Q9NQS5 1/20 0.37
▸ ATM Q13315 1/20 0.37
▸ CES1 P23141 1/20 0.36
▸ DNMT1 P26358 1/20 0.34
▸ MAPT P10636 2/20 0.33
▸ ALDH1A1 P00352 3/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ GAA P10253 1/20 0.32
▸ HPGD P15428 1/20 0.32
▸ CYP2A6 P11509 2/20 0.32
▸ TSHR P16473 2/20 0.32
▸ CYP1A2 P05177 1/20 0.32
▸ NCEH1 Q6PIU2 2/20 0.32
▸ MEN1 O00255 1/20 0.31
▸ RAB9A P51151 1/20 0.31
▸ KMT2A Q03164 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31
▸ HSD17B10 Q99714 1/20 0.31
▸ TDP1 Q9NUW8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2958679 0.92 NCEH1 (0.36) CES1ALDH1A1KDM4EGAAHPGD
SCHEMBL2963518 0.91 CNR1 (0.38) MAPTALDH1A1KDM4EGAAHPGD
SCHEMBL2975162 0.89 CNR1 (0.39) MAPTALDH1A1KDM4EGAAHPGD
SCHEMBL2964839 0.89 CNR1 (0.39) MAPTALDH1A1KDM4EGAAHPGD
SCHEMBL2967706 0.89 CNR1 (0.39) MAPTALDH1A1KDM4EGAAHPGD
SCHEMBL2973483 0.89 CNR1 (0.39) MAPTALDH1A1KDM4EGAAHPGD
SCHEMBL2969929 0.89 CNR1 (0.39) MAPTALDH1A1KDM4EGAAHPGD
SCHEMBL2959116 0.88 CES1 (0.41) ATMCES1DNMT1MAPTALDH1A1
SCHEMBL2967060 0.83 GPR84 (0.44) GPR84ATMCES1ALDH1A1KDM4E
SCHEMBL2964750 0.79 TSHR (0.46) ATMCES1DNMT1MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7763562-B2 Heteroatom bridged metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2010-07-27 — — US disclosed
US-7276567-B2 Heterocyclic substituted metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-10-02 — — US disclosed
US-20070135597-A1 Heteroatom bridged metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. 2007-06-14 — — US disclosed
US-7214747-B2 Phosphorus substituted metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-05-08 — — US disclosed
US-7214746-B2 Phosphorus bridged metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-05-08 — — US disclosed
US-20050261449-A1 Heterocyclic substituted metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENT INC. 2005-11-24 — — US disclosed
US-20050239981-A1 Phosphorus bridged metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. 2005-10-27 — — US disclosed
US-20050239980-A1 Phosphorus substituted metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. 2005-10-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050239981-A1 Phosphorus bridged metallocene compounds for olefin polymerization PYM1, ZNF207, POLL GPR84 4109/4885ATM 1504/4885CES1 4742/4885
US-20070135597-A1 Heteroatom bridged metallocene compounds for olefin polymerization AP2M1, AP1M1, PYM1 GPR84 3428/4885ATM 2370/4885CES1 4655/4885
US-20050239980-A1 Phosphorus substituted metallocene compounds for olefin polymerization CCRL2, ARL1, OSBP2 GPR84 3376/4885ATM 3155/4885CES1 4681/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback